The correlation between the methylation levels of SCNN1B and the clinicopathological parameters of the CRC patients, such as age, sex, tumour differentiation, tumour stage, lymph node metastasis, tumour localization, RAS mutation, BRAF mutation, and MSI status, was evaluated. This evidence concerns the gene SCNN1B and metastatic malignant neoplasm in the lymph nodes.